However, that costs time and money, and the document looks the same as the one on the FDA Web site. Due to the lack of easily obtainable information, an engineer or regulatory affairs officer may ...
STEMart announces the expansion of its genetic toxicology capabilities with the In Vivo Rat Micronucleus Test services.
Cellulose dermal filler achieves critical biocompatibility milestones, paving the way for clinical trials OTTAWA, ON, April 29, 2025 /CNW/ - Spiderwort Biotechnologies Inc., a pioneering biotechnology ...
Brinkman brings more than 15 years of experience in biological sciences and is known for her rigorous, clinically relevant approach to biological risk evaluation "We're thrilled to welcome Katie to ...
MILPITAS, Calif.--(BUSINESS WIRE)--SMI (Silicon Microstructures, Inc.) is pleased to announce that biocompatibility of IntraSense™ has been confirmed at a major medical device manufacturer.
WINNIPEG, Manitoba, March 22, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Kane Biotech,” or “the Company”) announced positive results from biocompatibility and in vivo safety ...
In the test, the chemicals leaching off of the device are compared with a searchable database that provides background on toxicity and the Cramer classification. The proposed change in the standard ...
(MENAFN- EIN Presswire) EINPresswire/ -- STEMart, a US-based provider of comprehensive services for all phases of medical device development, has announced the expansion of its genetic toxicology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results